123I-INF-1

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug Name123I-INF-1

Drug Alias Nameiodine-123-INF-1INF-1-[123I]123I-INF-1

ClassificationSmall moleculesRadiation-emitting products

Mechanisms of ActionC-X-C motif chemokine receptor 4 modulatorsSPECT contrast agent

TargetsC-X-C motif chemokine receptor 4

Therapy Area/IndicationsAtherosclerosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesNordion

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesNordion

Active IndicationsN/A

Inactive IndicationsAtherosclerosis

ATC CodeN/A